Peptic ulcer disease is characterized by inflammation of the stomach or duodenal linings caused by gastric acid penetrating the protective mucus barrier. The most common cause is infection by Helicobacter pylori bacteria, which lives in the stomach mucus and weakens its protective abilities. Approximately 4 million Americans have peptic ulcers. Symptoms include abdominal pain relieved by food or antacids. Treatment depends on the cause but commonly involves antibiotics, medications to reduce acid production, and lifestyle changes. Complications can include bleeding, perforation, or narrowing of the stomach outlet.
Homeopathy is highly scientific, logical, safe, quick and extremely effective method of healing. It offers long lasting to permanent cure, treating the disease from its roots, for most of the ailments.
Homeopathy is the most rational science with respect to its concepts of health, disease and cure. Homeopathy does not treat superficially by just driving away the symptoms but heals the patient from within.
Undoubtedly, homeopathy is the medicine of future.
The remedies are prepared from natural substances to precise standards and work by stimulating the body’s own healing power.
But in case of injuries caused to the body from without, the surgical treatment is necessary only to the extent that the parts injured require mechanical aid whereby the external obstruction to cure is removed mechanically. But in such injuries also the living organism requires active dynamic aid to put it in a position to restore the organism to health and homeopathic treatment is called for.homeopathic remedies can play a vital role in reducing any complications that may arise as well as accelerating healing and recovery.
Talking about gastritis & peptic ulcer disease ( definetions , clinical picture , diagnosis & treatment , complications ) , all informations are Up tu date of 2017
Homeopathy is highly scientific, logical, safe, quick and extremely effective method of healing. It offers long lasting to permanent cure, treating the disease from its roots, for most of the ailments.
Homeopathy is the most rational science with respect to its concepts of health, disease and cure. Homeopathy does not treat superficially by just driving away the symptoms but heals the patient from within.
Undoubtedly, homeopathy is the medicine of future.
The remedies are prepared from natural substances to precise standards and work by stimulating the body’s own healing power.
But in case of injuries caused to the body from without, the surgical treatment is necessary only to the extent that the parts injured require mechanical aid whereby the external obstruction to cure is removed mechanically. But in such injuries also the living organism requires active dynamic aid to put it in a position to restore the organism to health and homeopathic treatment is called for.homeopathic remedies can play a vital role in reducing any complications that may arise as well as accelerating healing and recovery.
Talking about gastritis & peptic ulcer disease ( definetions , clinical picture , diagnosis & treatment , complications ) , all informations are Up tu date of 2017
Ulcers range from small, painful sores in the mouth to bedsores and serious lesions of the stomach or interstine
Gastric ulcers :are peptic ulcers in the stomach.
Duodenal ulcers :are peptic ulcers in the duodenum
I am a professional pharmacist. These slides provide for pharmacy department students. These slides describe pathology some topics.
Such as peptic ulcer disease, Immunity etc.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Pud
1. MirelaStancu, MD
Definition
Peptic ulcer disease is characterized by variable degrees of inflammation involving gastric (gastritis) and duodenal
linings (duodenitis), caused when gastric acid (gastric juice) penetrates the protective mucus barrier. Depending on
the severity of disease, patients may develop superficial erosions limited to the most inner layer of the stomach or
duodenum (mucosa) or deep, penetrating ulcers involving the entire gastric or duodenal wall.
Epidemiology
It is estimated that 4 million Americans have peptic ulcer disease.
The most common cause for peptic ulcer disease is infection with a spiral shaped bacterium called Helicobacter
pylori (H. pylori). H. pylori lives within the protective mucus layer that coats the gastric lining (mucosa). This
organism can weaken the mucus layer and allow the damaging gastric juice to irritate the gastric lining resulting in
acute or chronic inflammation (gastritis). It is not currently known how this organism is spread, but it appears to be
transmitted from person to person through close contact and by ingesting contaminated food or water. H. pylori
gastritis is one of the most common infections in the world, more common in the developing than the industrialized
(Western) countries. In the United States, 20% of the young adults and about 50% of the patients older than 60, are
infected. The infection appears to be acquired in the childhood and remains throughout the life, until cured by
antibiotic treatment.
The next most common cause for peptic ulcer disease is long-term use of pain relieving drugs (aspirin, Advil,
Motrin, Aleve, Ketoprofen, and others, collectively named NSAIDs - Non Steroidal Anti-Inflammatory Drugs).
These drugs can damage the gastric or duodenal mucosa by two mechanisms: 1) they block the release of a
cytoprotective substance (prostaglandin) from the inflammatory cells in the stomach, and 2) they can induce direct
damage by lodging within the gastric or duodenal mucosa. When used sporadically and in small amount, the
NSAIDs can cause minimal or no tissue damage, especially if taken with large quantities of water (at least 8 oz),
with food, milk or antiacids. However, when used regularly or in large quantities, these drugs can lead to chronic
gastritis and ulcers.
Other causes of gastritis include excessive alcohol use (hemorrhagic gastritis), reflux of bile into the stomach (bile
reflux gastritis), antibodies produced by the immune system against certain cells in the gastric mucosa (autoimmune
gastritis) and stress.
Symptoms
The most common symptom of ulcer is gnawing or burning pain in the upper abdomen. The pain may come and go
for several days or weeks, starts about 2-3 hours after a meal, may occur in the middle of the night, and is relieved by
food or antiacid medication.
Other symptoms include nausea, vomiting, bloating, belching, poor appetite, weight loss.
Emergency signs and symptoms that should prompt a visit to the physician include sharp, sudden and persistent
stomach pain, bloody or black stools and bloody or black (similar to coffee ground) vomitus. These signs may
2. indicate serious complications such as perforated ulcer, bleeding ulcer or narrowing (stenosis) of the gastric outlet.
Diagnosis
Several tests are routinely recommended for the diagnosis of gastric or duodenal ulcer: upper gastrointestinal series
(X-ray of the esophagus, stomach and duodenum) and/or upper endoscopy. The X-rays are taken after drinking a
white, milky liquid (barium) that coats the lining of the digestive organs allowing to see any defect in the lining that
indicates the presence of ulcer. During the upper endoscopy a thin tube equipped with a video camera (endoscope) is
placed in the esophagus, stomach and duodenum. The images captured by the camera are transmitted to a video
monitor and examined by the endoscopist during the procedure. An ulcer appears like a defect (hole) in the mucosal
lining, that could be covered by blood or have a clean, white base. During the same procedure, tiny tissue fragments
(biopsies) can be removed from the diseased area and sent to the pathology lab for microscopic examination and
diagnosis.
Once a diagnosis of peptic ulcer disease is confirmed, additional tests are necessary to determine the cause of the
ulcer, because different types of ulcers are treated differently.
Blood tests are usually ordered to check for the presence of antibodies against H. pylori. A positive test indicates that
the patient came in contact, recently or in the past, with the bacterium, but it doesn't necessarily indicate current
infection.
Breath test for H. pylori is an effective diagnostic test, performed in the doctor's office, during which the patient
drinks a solution of urea (a chemical compound that is metabolized by an enzyme called urease, secreted by H.
pylori). This compound is marked with a special carbon atom, which is released in the blood when the urease breaks
down the urea. The blood carries the carbon to the lungs, where the patient exhales it. This test is very accurate and if
positive, indicates the presence of current infection with H. pylori.
Stool tests detect the presence of H. pylori bacteria in the fecal material and if positive, indicate the presence of
current infection.
The tissue tests use mucosal samples (biopsies) removed during upper endoscopy, for the diagnosis of H. pylori. One
test (rapid urease test, Pyloritek) detects the urease enzyme produced by H. pylori. Another test consists of
examination of the tissue under the microscope and uses special stains that highlight the microorganisms.
Clinical Course and Complications
The clinical course may be prolonged and can be complicated by bleeding, acute perforation and peritonitis, or
narrowing of the gastric outlet leading to vomiting and weight loss. Another rare complication is gastric cancer.
Treatment Options
The treatment of peptic ulcer disease depends on the specific causes and may require lifestyle changes (stop smoking
and alcohol use, limit the intake of spicy foods), medical treatment or, rarely, surgery.
The medical treatment in the case of H. pylori gastritis is aimed at killing the bacteria, reducing the gastric acid and
protecting the gastric lining. Antibiotics that are routinely used for killing H. pylori include metronidazole,
3. tetracycline, clarithromycin and amoxicillin. Antiacid medication is used in conjunction with antibiotic therapy in
order to decrease the amount of gastric acid, help heal the ulcer and reduce the gastric pain. The most potent acid-
suppressing drugs are the proton pump inhibitors such as omeprazole, lansoprazole, esomeprazole and pantoprazole.
The mucosal protectors (bismuth subsalicylate) are used to protect the stomach lining from the damaging effect of
the gastric acid.
These agents must be used in combination in order to be effective in eradication of H. pylori infection. The most
commonly used regimen called the triple therapy, involves two antibiotics and either an acid suppressor or a mucosal
protector taken daily for two weeks.
Surgery may be needed for those patients in whom the ulcers fail to heal or develop complications (bleeding,
perforation or obstruction). During the surgery, the surgeon my remove the ulcer together with a narrow rim of
tissue, or, depending on the size and location of the ulcer, may remove the entire lower portion of the stomach
together with part of the duodenum.
Patients that have peptic ulcer disease due to long standing treatment with pain relievers (NSAIDs) should substitute
their current drugs with different pain-relief medications that are not as damaging to the gastric or duodenal lining
(for example, acetaminophen). In addition, they should consult with their doctor regarding adding a mucosal
protective drug to their regular anti-inflammatory treatment.
More Information
Additional information about gastric disorders:
National Digestive Diseases
The American Gastroenterological Association
Mayo Clinic
Helicobacter pylori Foundation
<< PREVIOUS | HOME
Healthcare Professionals Patients and General Public